Related Experiment Video
Updated: May 15, 2025

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
[Retracted] Promoter methylation of RASSF1A modulates the effect of the microtubule‑targeting agent docetaxel in
Eun Young Gil1, Uk Hyun Jo1, Hoiseon Jeong2
1Division of Oncology/Hematology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul 136-705, Republic of Korea.
Abstract:
Following the publication of this paper, and a corrigendum that was subsequently published to take account of anomalies that were identified with the assembly of western blot data in Fig. 5B (doi: 10.3892/ijo.2017.3900), a concerned reader drew to the Editor's attention that, regrettably, there remained possible issues with the duplication of data in the revised version of Fig. 5 provided by the authors in the Corrigendum; in addition, potential anomalies were also noted with the western blot assay data in the originally published versions of Fig. 2A and B. After having performed an independent review of the data in these figures in the Editorial Office, the concerns of the reader were found to be validated. Therefore, the Editor of International Journal of Oncology has decided that this paper should now be retracted from the Journal. After contacting the authors, they accepted the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [International Journal of Oncology 41: 611‑620, 2012; DOI: 10.3892/ijo.2012.1470].
Related Concept Videos
Epigenetic Regulation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Master Transcription Regulators

